<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Duty Exemption Granted for Formulation with Specified Bulk Drug Under Notification 6/02-CE, Serial No. 57.</title>
    <link>https://www.taxtmi.com/highlights?id=25974</link>
    <description>Claim of exemption under notification no. 6/02-CE (serial No. 57) of a formulation made from two bulk drugs - Diphenoxylate Hydrochloride with Atropine Sulphate. - if a formulation consist of more than one bulk drug, and out of those bulk drugs only one bulk drug is specified in notification the duty exemption to the formulation cannot be denied. - AT</description>
    <language>en-us</language>
    <pubDate>Wed, 18 Nov 2015 15:21:05 +0530</pubDate>
    <lastBuildDate>Wed, 18 Nov 2015 15:21:05 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=405608" rel="self" type="application/rss+xml"/>
    <item>
      <title>Duty Exemption Granted for Formulation with Specified Bulk Drug Under Notification 6/02-CE, Serial No. 57.</title>
      <link>https://www.taxtmi.com/highlights?id=25974</link>
      <description>Claim of exemption under notification no. 6/02-CE (serial No. 57) of a formulation made from two bulk drugs - Diphenoxylate Hydrochloride with Atropine Sulphate. - if a formulation consist of more than one bulk drug, and out of those bulk drugs only one bulk drug is specified in notification the duty exemption to the formulation cannot be denied. - AT</description>
      <category>Highlights</category>
      <law>Central Excise</law>
      <pubDate>Wed, 18 Nov 2015 15:21:05 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/highlights?id=25974</guid>
    </item>
  </channel>
</rss>